Cargando…

Gastric Cancer Mesenchymal Stem Cells Inhibit NK Cell Function through mTOR Signalling to Promote Tumour Growth

The dysfunction of natural killer (NK) cells has been increasingly reported in malignancies, especially in solid tumours. Mesenchymal stem cells (MSCs) exhibit pleiotropic functions that include mediating immune cell exhaustion which is implicated in cancer progression. However, the association of M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Shuwei, Huang, Chao, Han, Fengfeng, Chen, Bin, Ding, Ying, Zhao, Yuanyuan, Chen, Zhihong, Wen, Shaodi, Wang, Mei, Shen, Bo, Zhu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263240/ https://www.ncbi.nlm.nih.gov/pubmed/34306099 http://dx.doi.org/10.1155/2021/9989790

Ejemplares similares

Transcriptional Regulation of NK Cell Development by mTOR Complexes
por: Yang, Chao, et al.
Publicado: (2020)

Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells
por: Wang, Qianqian, et al.
Publicado: (2022)

Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
por: Sun, Li, et al.
Publicado: (2018)

Gastric cancer mesenchymal stem cells inhibit natural killer cell function by up-regulating FBP1
por: Han, Fengfeng, et al.
Publicado: (2021)

mTOR Overactivation in Mesenchymal cells Aggravates CCl(4)− Induced liver Fibrosis
por: Shan, Lanlan, et al.
Publicado: (2016)

mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein
por: Guglielmelli, Tommasina, et al.
Publicado: (2015)

Revisiting mTOR and Epithelial–Mesenchymal Transition
por: Herrerias, Mariana M., et al.
Publicado: (2020)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer
por: Cao, Guo-dong, et al.
Publicado: (2016)

Dual Target of EGFR and mTOR Suppresses Triple-Negative Breast Cancer Cell Growth by Regulating the Phosphorylation of mTOR Downstream Proteins
por: Ma, Jing, et al.
Publicado: (2023)

SERPINA5 promotes tumour cell proliferation by modulating the PI3K/AKT/mTOR signalling pathway in gastric cancer
por: Fan, Meiyang, et al.
Publicado: (2022)

Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis
por: Sun, Li, et al.
Publicado: (2020)

Pml represses tumour progression through inhibition of mTOR
por: Bernardi, Rosa, et al.
Publicado: (2011)

The metabolic checkpoint kinase mTOR is essential for interleukin-15 signaling during NK cell development and activation
por: Marçais, Antoine, et al.
Publicado: (2014)

mTOR sends T cells on their way
por: LeBrasseur, Nicole
Publicado: (2008)

Matrix IGF-1 regulates bone mass by activation of mTOR in mesenchymal stem cells
por: Xian, Lingling, et al.
Publicado: (2012)

2,5-dimethylcelecoxib alleviated NK and T-cell exhaustion in hepatocellular carcinoma via the gastrointestinal microbiota-AMPK-mTOR axis
por: Pan, Banglun, et al.
Publicado: (2023)

High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling
por: Zhang, Dayong, et al.
Publicado: (2017)

Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and Osteoclasts
por: Wu, Hongguang, et al.
Publicado: (2017)

mTOR and ROS regulation by anethole on adipogenic differentiation in human mesenchymal stem cells
por: Rhee, Yun-Hee, et al.
Publicado: (2018)

Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells
por: Antonioli, Eliane, et al.
Publicado: (2019)

The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF
por: Vetters, Jessica, et al.
Publicado: (2019)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

G6PD-NF-κB-HGF Signal in Gastric Cancer-Associated Mesenchymal Stem Cells Promotes the Proliferation and Metastasis of Gastric Cancer Cells by Upregulating the Expression of HK2
por: Chen, Bin, et al.
Publicado: (2021)

Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation()
por: Hibdon, Elise S., et al.
Publicado: (2019)

Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway
por: Yuan, Baoshi, et al.
Publicado: (2023)

mTOR-Dependent Cell Proliferation in the Brain
por: Ryskalin, Larisa, et al.
Publicado: (2017)

mTOR Regulation of Glycolytic Metabolism in T Cells
por: Salmond, Robert J.
Publicado: (2018)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
por: Wu, Mingsong, et al.
Publicado: (2015)

Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours
por: Seront, E, et al.
Publicado: (2013)

mTOR complexes differentially orchestrates eosinophil development in allergy
por: Zhu, Chen, et al.
Publicado: (2018)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Nanosecond Pulsed Electric Fields Enhance the Anti-tumour Effects of the mTOR Inhibitor Everolimus against Melanoma
por: Dai, Jie, et al.
Publicado: (2017)

Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
por: Hirashima, K, et al.
Publicado: (2012)

mTOR Inhibitors in Advanced Biliary Tract Cancers
por: Wu, Chao-En, et al.
Publicado: (2019)

All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
por: Gamper, Christopher J., et al.
Publicado: (2012)

Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors
por: Hassan, Burhan, et al.
Publicado: (2014)

PI3K/AKT/mTOR pathway in pulmonary carcinoid tumours
por: Zhang, Zixuan, et al.
Publicado: (2017)

Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
por: Dumas, Anaelle A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eisnt2dhq306duj6isteo6h8lp